期刊文献+

吴茱萸次碱通过Sirt1改善血管平滑肌细胞钙化 被引量:6

Rutecarpine Attenuates Vascular Smooth Muscle Cell Calcification via Sirt1
下载PDF
导出
摘要 【目的】探讨吴茱萸次碱对血管平滑肌细胞钙化的作用及机制。【方法】本研究采用大鼠血管平滑肌细胞钙化体外模型,用不同浓度的吴茱萸次碱处理细胞,qRT-PCR检测成骨样分化基因Runx2、BMP2和Osterix的表达和茜素红染色测细胞钙化程度。此外,观察吴茱萸次碱对血管平滑肌细胞Sirt1表达水平的影响以及Sirt1抑制剂对细胞钙化的影响。【结果】茜素红素染色及钙离子浓度定量实验均显示不同浓度的吴茱萸次碱可明显地改善高磷高钙诱导的大鼠血管平滑肌细胞的钙化程度(136±10、75±6、52±6、31±5、P <0.05)。使用吴茱萸次碱明显降低血管平滑肌细胞成骨样分化的分子标志物ALP活性,下调Runx2(2.85±0.25、1.75±0.18、1.62±0.13、1.36±0.16、P <0.05),BMP2(3.2±0.32、1.85±0.17、1.65±0.15、1.43±0.12,P <0.05)和Osterix(2.60±0.27、1.82±0.16、1.55±0.15、1.36±0.17;P <0.05)的表达水平,说明吴茱萸次碱可抑制血管平滑肌细胞成骨样分化过程。另外,高磷高钙可下调血管平滑肌细胞Sirt1的表达水平,qRT-PCR和Western blot结果证实吴茱萸次碱可明显地上调Sirt1 mRNA(0.35±0.06、0.75±0.11;0.22±0.08、0.87±0.13;P <0.05)和Sirt1的蛋白(0.38±0.09、0.71±0.13;P <0.05)的表达水平。钙定量结果显示Sirt1抑制剂EX-527能阻断吴茱萸次碱改善血管平滑肌细胞钙化的作用(138±13、36±7、87±8,P <0.05)。【结论】吴茱萸次碱可通过调节Sirt1改善血管平滑肌细胞钙化。 【Objective】This study aims to investigate whether rutecarpine has an effect on calcification of VSMC and its underlying mechanism.【Methods】In vitro model of rat VSMC calcification was used in this study. Rutecarpine at different concentrations was used to treat cultured rat VSMC. The expression of Runx2,BMP2 and Osterix was analyzed by qRT-PCR and mineral deposition was detected by alizarin red staining. In addition,we examined the effect of rutecarpine on Sirtuin-1(Sirt1)expression in VSMC and the effect of Sirt1 inhibitor on VSMC calcification.【Results】Alizarin red staining and calcium content assay showed that rutecarpine at different concentrations significantly reduced calcification of rat VSMC induced by high phosphorus and high calcium(136±10,75±6,52±6,31±5.29,P<0.05). Usage of rutecarpine decreased the activity of ALP,an osteogenic differentiation molecular marker,and down-regulated the expression of Runx2(2.85±0.25,1.75±0.18,1.62±0.13,1.36±0.16,P<0.05),BMP2(3.2±0.32,1.85±0.17,1.65±0.15,1.43±0.12,P<0.05)and Osterix(2.60±0.27,1.82±0.16,1.55±0.15,1.36±0.17,P<0.05),suggesting that rutecarpine inhibited osteogenic differentiation of VSMC. In addition,high phosphorus and high calcium down-regulated the expression of Sirt1 in VSMC. qRT-PCR and western blot analysis confirmed that rutecarpine up-regulated the expression of Sirt1 at both mRNA(0.35±0.06,0.75±0.11;0.22±0.08,0.87±0.13,P<0.05)and protein levels(0.38±0.09,0.71± 0.13,P<0.05). Quantification of calcium content analysis showed inhibition of Sirt1 by EX-527 blocked the inhibitory effect of rutecarpine on VSMC calcification(138±13,36±7,87±8,P<0.05).【Conclusion】We demonstrate that rutecarpine attenuates VSMC calcification via up-regulation of Sirt1.
作者 邵静 陈安 张秀丽 杨平珍 SHAO Jing;CHEN An;ZHANG Xiu-li;YANG Ping-zhen(Department of Cardiology// Laboratory of Heart Center,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China)
出处 《中山大学学报(医学版)》 CAS CSCD 北大核心 2019年第3期387-392,共6页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省科技计划项目(2013B021800323) 广东省科普计划项目(2014A020212191)
关键词 血管钙化 血管平滑肌细胞 吴茱萸次碱 沉默信息调节因子1 vascular calcification vascular smooth muscle cells rutecarpine sirtuin-1
  • 相关文献

参考文献1

二级参考文献29

  • 1Bao MH, Dai W, Li YJ, Hu CP. Rutaecarpine prevents hypoxia-reoxygenation-induced myocardial cell apoptosis via inhibition of NADPH oxidases. Can J Physiol Pharmacol 2011 ;89:177-186.
  • 2Liao JF, Chfou WF, Shen YC, Wang G J, Chen CF. Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components. Chin Med 2011 ;6:6-13.
  • 3Deng PY, Ye F, Cai W J, Tan GS, Hu CP, Deng HW, et al. Stimulation of calcitonin gene-related peptide synthesis and release: mechanisms for a novel antihypertensive drug, rutaecarpine. J Hypertens 2004;22:1819-1829.
  • 4Qin XP, Zeng SY, Li D, Chen QQ, Luo D, Zhang Z, et al. Calcitonin gene-related peptide-med(ated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats. J Cardiovasc Pharmacol 2007;50:654-659.
  • 5Chiou WF, Liao JF, Chen CF. Comparative study of the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J Nat Prod 1996;59:374-378.
  • 6Hung WW, Hsieh T J, Lin T, Chou PC, Hsiao P J, Lin KD, et al. Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes. Cardiovasc Drugs Ther 2011 ;25:3-12.
  • 7Touyz RM. The role of angiotensin Ⅱ in regulating vascularstructural and functional changes in hypertension. Curr Hypertens Rep 2003;5:155-164.
  • 8Alvin Z, Laurence GG, Coleman BR, Zhao A, Hajj-Moussa M, Haddad GE. Regulation of L-type inward calcium channel activity by captopril and angiotensin 1I via the phosphatidyl inositol 3-kinase pathway in cardiomyocytes from volume-overload hypertrophied rat hearts. Can J Physiol Pharmacol 2011 ;89:206-215.
  • 9Ruiz-Ortega M, Ruperez M, Esteban V, Egido J. Molecular mechanisms of angiotensin I] -induced vascular injury. Curr Hypertens Rep 2003;5:73-79.
  • 10Suzuki H, Motley ED, Frank GD, Utsunomiya H, Eguchi S. Recent progress in signal transduction research of the angiotensin ]] type-1 receptor: protein kinases, vascular dysfunction and structural requirement. Curr Med Chem Cardiovasc Hematol Agents 2005;3:305-322.

共引文献14

同被引文献142

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部